首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

到 2030 年南美洲和中美洲分子诊断市场预测 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户

市场调查报告书

商品编码

1452579

到 2030 年南美洲和中美洲分子诊断市场预测 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户

South & Central America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

出版日期: 2024年01月05日 | 出版商:

The Insight Partners | 英文 102 Pages | 订单完成后即时交付

价格

简介目录图表

南美洲和中美洲分子诊断市场预计将从2022年的12.2128亿美元成长到2030年的26.7914亿美元。预计2022年至2030年CAGR为10.3%。

分子诊断技术的进步推动了南美洲和中美洲分子诊断市场

分子诊断技术和平台正在应用于解剖学和临床病理学的所有领域。与疾病相关的 DNA 或 RNA 序列，包括单核苷酸多态性、缺失、重排和插入，可在分子诊断测试中检测到。 COVID-19出现后，分子诊断得到了进一步的改进。传统上，CT扫描、血液学检测和RT-PCR用于检测。随着 2020 年 COVID-19 病例的快速增长，对快速、精确的检测平台的需求激增，以克服传统检测的缺点。电脑断层扫描 (CT) 是一种成本密集型检查，可能并非所有医院都能提供，无法检测无症状患者的病毒感染和其他疾病。广泛使用的RT-PCR也耗时且昂贵，无法检测感染早期的低病毒量。因此，研究人员开发了检测 SARS-CoV-2 的新方法，这种方法更快、更具成本效益。逆转录环介导等温扩增 (RT-LAMP)、基于微阵列的检测、基于适体的诊断、SHERLOCK、SHERLOCKv2、FET 生物感测器、基于细胞的电位诊断和分子印迹技术是新型分子诊断的一些例子为COVID-19 诊断所开发的技术。在过去几年中，FDA 报告显示分子检测、抗原依赖性检测和血清学检测的进步已获得批准。不同国家的科学界为管理 COVID-19 大流行和降低死亡率而共同努力，使整个分子工具和诊断领域受益，这可能会在未来为分子诊断市场创造重大机会。

南美洲和中美洲分子诊断市场概述

南美洲和中美洲的分子诊断市场分为阿根廷、巴西以及南美洲和中美洲的其他地区。该地区的市场成长归因于人口老化、诊断市场的成长以及医疗器材行业主要参与者的不断增加的倡议。此外，慢性病的流行需要有前景的诊断测试选择，这有助于该地区的市场成长。

南美洲和中美洲分子诊断市场收入及 2030 年预测（百万美元）

南美洲和中美洲分子诊断市场细分

南美洲和中美洲分子诊断市场分为疾病领域、技术、产品和服务、最终用户和国家。

根据疾病领域，南美洲和中美洲分子诊断市场分为传染病、肿瘤学、基因检测、心臟病、免疫系统疾病等。 2022 年，传染病细分市场在南美洲和中美洲分子诊断市场占有率中占据最大份额。

根据技术，南美洲和中美洲分子诊断市场分为聚合酶链反应（PCR）、原位杂交、等温核酸扩增技术（INAAT）、DNA定序和下一代定序（NGS）、DNA微阵列和其他的。聚合酶链反应 (PCR) 细分市场在 2022 年占据南美洲和中美洲分子诊断市场最大份额。聚合酶链反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。

根据产品和服务，南美洲和中美洲分子诊断市场分为检测和试剂盒、仪器、服务和软体。 2022 年，检测和试剂盒领域在南美洲和中美洲分子诊断市场份额中占据最大份额。

根据最终用户，南美洲和中美洲分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。 2022 年，诊断实验室领域占据南美洲和中美洲最大的分子诊断市场。

根据国家/地区，南美洲和中美洲分子诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西将主导南美洲和中美洲分子诊断市场。

Abbott Laboratories、bioMerieux SA、Danaher、F. Hoffmann-La Roche Ltd、Illumina Inc、Novartis AG、Qiagen NV、Siemens Healthineers AG 和 Thermo Fisher Scientific Inc. 是南美洲和中美洲分子诊断领域的一些领先公司市场。

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

South & Central America Molecular Diagnostics Market Overview

The molecular diagnostics market in South & Central America is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the aging population, growing diagnostics market, and the increasing initiatives by major players in the medical device industry. Furthermore, the prevalence of chronic diseases that demand promising diagnostic test options contributes to the market growth in the region.

South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Molecular Diagnostics Market Segmentation

The South & Central America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the South & Central America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on technology, the South & Central America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest South & Central America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the South & Central America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on end users, the South & Central America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest South & Central America molecular diagnostics market share in 2022.

Based on country, the South & Central America molecular diagnostics market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America molecular diagnostics market in 2022.

Abbott Laboratories, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd, Illumina Inc, Novartis AG, Qiagen NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America molecular diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 South & Central America PEST Analysis

5. South & Central America Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - South & Central America Market Analysis

6.1 South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 qPCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Molecular Diagnostics Market - Country Analysis

11.1 South & Central America Molecular Diagnostics Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 South & Central America Molecular Diagnostics Market by Country
- 11.1.2 Brazil
  - 11.1.2.1 Overview
- 11.1.3 Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.4 Brazil: Molecular Diagnostics Market, by Disease Area
- 11.1.5 Brazil: Molecular Diagnostics Market, by Technology
  - 11.1.5.1 Brazil: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.6 Brazil: Molecular Diagnostics Market, by Product and Services
- 11.1.7 Brazil: Molecular Diagnostics Market, by End User
- 11.1.8 Argentina
  - 11.1.8.1 Overview
- 11.1.9 Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.10 Argentina: Molecular Diagnostics Market, by Disease Area
- 11.1.11 Argentina: Molecular Diagnostics Market, by Technology
  - 11.1.11.1 Argentina: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.12 Argentina: Molecular Diagnostics Market, by Product and Services
- 11.1.13 Argentina: Molecular Diagnostics Market, by End User
- 11.1.14 Rest of South & Central America
  - 11.1.14.1 Overview
- 11.1.15 Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.16 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
- 11.1.17 Rest of South & Central America Molecular Diagnostics Market, by Technology
  - 11.1.17.1 Rest of South & Central America: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.18 Rest of South & Central America: Molecular Diagnostics Market, by Product and Services
- 11.1.19 Rest of South & Central America: Molecular Diagnostics Market, by End User

12. South & Central America Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. South & Central America Molecular Diagnostics Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Qiagen NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 bioMerieux SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Illumina Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Danaher
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Siemens Healthineers AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Novartis AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. South & Central America Molecular Diagnostics Market Segmentation
Table 2. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 3. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 4. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 5. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
Table 6. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 7. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 8. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 9. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 10. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
Table 11. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 12. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 13. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 14. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 15. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 16. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

Figure 1. South & Central America - PEST Analysis
Figure 2. South & Central America Molecular Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Molecular Diagnostics Market, By Country, 2022 (US$ Mn)
Figure 33. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Growth Strategies Done by the Companies in the Market (%)